Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice Article Swipe
Related Concepts
Medicine
Hazard ratio
Conventional PCI
Bioresorbable scaffold
Confidence interval
Clinical endpoint
Everolimus
Thrombosis
Percutaneous coronary intervention
Surgery
Internal medicine
Target lesion
Stent
Clinical trial
Radiology
Nuclear medicine
Myocardial infarction
Joo Myung Lee
,
Hyun Sung Joh
,
Ki Hong Choi
,
David Hong
,
Taek Kyu Park
,
Jeong Hoon Yang
,
Young Bin Song
,
Jin‐Ho Choi
,
Seung‐Hyuk Choi
,
Jin‐Ok Jeong
,
Jong‐Young Lee
,
Young Jin Choi
,
Jei Keon Chae
,
Seung‐Ho Hur
,
Jang‐Whan Bae
,
Ju Hyeon Oh
,
Kook Jin Chun
,
Hyun Joong Kim
,
Byung Ryul Cho
,
Doosup Shin
,
Seung Hun Lee
,
Doyeon Hwang
,
Hyun‐Jong Lee
,
Ho‐Jun Jang
,
Hyun Kuk Kim
,
Sang Jin Ha
,
Eun‐Seok Shin
,
Joon‐Hyung Doh
,
Joo‐Yong Hahn
,
Hyeon‐Cheol Gwon
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.3346/jkms.2023.38.e34
· OA: W4315796003
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.3346/jkms.2023.38.e34
· OA: W4315796003
ClinicalTrials.gov Identifier: NCT02601404, NCT04265443.
Related Topics
Finding more related topics…